Discounted Cash Flow (DCF) Analysis Levered
Healthcare Special Opportunities Fu... (MDS-UN.TO)
$11.84
+0.53 (+0.00%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 8.23 | 5.15 | 5.82 | 2.12 | 1.53 | 1.09 | 0.77 | 0.55 | 0.39 | 0.28 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | 29.58 | 11.50 | 3.35 | 1.85 | 3.72 | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | - | - | - | - | - | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
Weighted Average Cost Of Capital
Share price | $ 11.84 |
---|---|
Beta | 0.000 |
Diluted Shares Outstanding | 2.63 |
Cost of Debt | |
Tax Rate | 3.10 |
After-tax Cost of Debt | -% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 4.542 |
Total Debt | - |
Total Equity | 31.14 |
Total Capital | - |
Debt Weighting | - |
Equity Weighting | - |
Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 8.23 | 5.15 | 5.82 | 2.12 | 1.53 | 1.09 | 0.77 | 0.55 | 0.39 | 0.28 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | 29.58 | 11.50 | 3.35 | 1.85 | 3.72 | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | 2.11 | 1.50 | 1.07 | 0.76 | 0.54 |
WACC | ||||||||||
PV LFCF | - | - | - | - | - | |||||
SUM PV LFCF | - |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | - |
Free cash flow (t + 1) | 0.55 |
Terminal Value | - |
Present Value of Terminal Value | - |
Intrinsic Value
Enterprise Value | - |
---|---|
Net Debt | -3.33 |
Equity Value | - |
Shares Outstanding | 2.63 |
Equity Value Per Share | - |